Cargando…

Change in Patient-Reported Outcome Measures as Predictors of Revision Lumbar Decompression Procedures

OBJECTIVE: To assess change in Patient-Reported Outcome Measures (PROM) as predictors for revision lumbar decompression (LD). METHODS: Patients who underwent primary, single or multilevel LD were retrospectively reviewed. Patients were categorized according to whether or not they underwent revision...

Descripción completa

Detalles Bibliográficos
Autores principales: Nolte, Michael T., Cha, Elliot D.K., Lynch, Conor P., Jacob, Kevin C., Patel, Madhav R., Geoghegan, Cara E., Jadczak, Caroline N., Mohan, Shruthi, Singh, Kern
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Spinal Neurosurgery Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752697/
https://www.ncbi.nlm.nih.gov/pubmed/35000342
http://dx.doi.org/10.14245/ns.2142230.115
Descripción
Sumario:OBJECTIVE: To assess change in Patient-Reported Outcome Measures (PROM) as predictors for revision lumbar decompression (LD). METHODS: Patients who underwent primary, single or multilevel LD were retrospectively reviewed. Patients were categorized according to whether or not they underwent revision LD within 2 years of the primary procedure. Visual analogue scale (VAS), Oswestry Disability Index (ODI), 12-item Short Form Health Survey and 12-item Veterans RAND physical component score (SF-12 PCS and VR-12 PCS), and Patient-Reported Outcome Measurement Information System physical function (PROMIS-PF) were recorded. Delta PROM scores were evaluated for differences between groups and as a risk factor for a revision LD. RESULTS: The study included 135 patients, 91 undergoing a primary procedure only and 44 undergoing a primary and revision procedure. Matched patients did not demonstrate any significant differences in demographics or perioperative characteristics. Patients who underwent a revision had a mean time to revision of 7.4 ± 5.7 months. Primary cohort significantly improved for all PROMs (all p < 0.05), while the primary plus revision cohort significantly improved for VAS back, ODI, and PROMIS-PF (all p < 0.05). However, cohorts differed in VAS back and PROMIS-PF (p < 0.05). Delta PROMs were not a significant risk factor for revision except at 6 months for PROMIS-PF (p = 0.024). CONCLUSION: LD has been associated with reliable outcomes, but early identification of patients at risk for revision is critical. This study suggests that tools such as PROMIS-PF may serve a role in predicting who is at risk and the 6-month follow-up period may be valuable for counseling patients who are not experiencing improvement.